{"id":16478,"date":"2025-07-15T13:30:18","date_gmt":"2025-07-15T13:30:18","guid":{"rendered":"https:\/\/genekor.com\/2025\/07\/15\/pik3ca-pole-and-msiincorporated-in-the-updated-nccn-guidelines-for-adjuvant-therapy-in-early-stage-crc\/"},"modified":"2025-07-16T06:35:11","modified_gmt":"2025-07-16T06:35:11","slug":"pik3ca-pole-msi-ghiduri-nccn-terapie-adjuvanta-cancer-colon-stadiu-incipient","status":"publish","type":"post","link":"https:\/\/genekor.com\/ro\/2025\/07\/15\/pik3ca-pole-msi-ghiduri-nccn-terapie-adjuvanta-cancer-colon-stadiu-incipient\/","title":{"rendered":"PIK3CA, POLE \u0219i MSI incluse \u00een ghidurile NCCN actualizate pentru a orienta terapia adjuvant\u0103 \u00een CCR \u00een stadiu incipient"},"content":{"rendered":"\n<p>\u00cen urma prezent\u0103rii <a href=\"https:\/\/mcusercontent.com\/84034efa59a7e43f306956007\/files\/94270538-3fd9-8b84-07d7-ce4aa8a388fe\/lindberg_et_al_2025_low_dose_aspirin_to_reduce_recurrence_rate_in_colorectal_cancer_patients_with_pi3k_pathway.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">studiului ALASCCA la simpozionul ASCO GI 2025<\/a>, aspirina a devenit o terapie adjuvant\u0103 promi\u021b\u0103toare la pacien\u021bii cu cancer colorectal (CCR) \u00een stadiu II-III cu alter\u0103ri ale c\u0103ii PI3K, prezente la 37% dintre participan\u021bii studiului, \u00een special <strong>muta\u021bii<\/strong> <strong>PIK3CA<\/strong>. Pe baza acestor constat\u0103ri, <strong>testele pentru PIK3CA sunt acum incluse \u00een ultimele Ghiduri NCCN<\/strong>, recomand\u00e2nd s\u0103 se aib\u0103 \u00een vedere aspirina \u00een cazul acestui subgrup definit molecular.<br><br>\u00cen paralel, <strong>Ghidurile NCCN actualizate pentru cancerul de colon \u00een stadiu incipient<\/strong>\u00a0eviden\u021biaz\u0103 acum <strong>muta\u021biile POLE<\/strong>, al\u0103turi de <strong>dMMR\/MSI-H<\/strong>, ca markeri pentru un prognostic favorabil. \u00cen special, <strong>muta\u021biile POLE apar \u00een aproximativ 2,09% din cazurile de CCR \u00een stadiu II \u0219i 0,66% din cele \u00een stadiu III <\/strong>\u0219i <strong>nu pot coexista cu \u00a0deficien\u021ba de reparare a \u00eemperecherilor gre\u0219ite <\/strong>(<a href=\"https:\/\/mcusercontent.com\/84034efa59a7e43f306956007\/files\/58c37fdc-dfe4-307e-1f4b-2dc01f0d752e\/domingo2016.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">cite\u0219te mai mult)<\/a>. De\u0219i datele prospective r\u0103m\u00e2n limitate, integrarea acestor markeri \u00een algoritmii clinici sus\u021bine stratificarea riscului \u0219i reducerea eventual\u0103 a terapiei adjuvante \u00een anumite subgrupuri.<br><br>De\u0219i ghidul NCCN actual nu recomand\u0103 utilizarea de rutin\u0103 a testelor multigenice extinse pentru stabilirea terapiei adjuvante \u00een CCR \u00een stadiu incipient, datele recente sugereaz\u0103 c\u0103 markerii genomici selecta\u021bi pot orienta individualizarea tratamentului.<strong> Panelul Com.pl.i.t DX Colon<\/strong>, deja utilizat \u00een CCR metastatic (CCRm), include <strong>statusul <\/strong>\u00a0<strong>PIK3CA, POLE \u0219i MSI<\/strong>, oferind un profil molecular cuprinz\u0103tor, care este \u00een concordan\u021b\u0103 cu aceste perspective clinice \u00een evolu\u021bie. Dat fiind dovezile din ce \u00een ce mai numeroase, <strong>Com.pl.i.t DX Colon poate reprezenta un instrument valoros pentru documentarea deciziilor de tratament \u00een cancerul de<\/strong> <strong>colon \u00een stadiu incipient (stadiu II\u2013III)<\/strong>, ajut\u00e2nd at\u00e2t \u00een strategiile de cre\u0219tere a tratamentului (de ex., terapia cu aspirin\u0103 pentru tumori cu muta\u021bii PIK3CA) c\u00e2t \u0219i \u00een cele de reducere (de ex., evitarea tratamentului excesiv pentru tumorile cu muta\u021bii POLE sau MSI-H).<\/p>\n\n\n\n<p>Cele mai noi Ghiduri NCCN: \u00a0<a href=\"https:\/\/genekor.com\/wp-content\/uploads\/2025\/07\/NCCN_Guidelines.pdf\">https:\/\/genekor.com\/wp-content\/uploads\/2025\/07\/NCCN_Guidelines.pdf<\/a><\/p>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u00cen urma prezent\u0103rii studiului ALASCCA la simpozionul ASCO GI 2025, aspirina a devenit o terapie adjuvant\u0103 promi\u021b\u0103toare la pacien\u021bii cu cancer colorectal (CCR) \u00een stadiu II-III cu alter\u0103ri ale c\u0103ii [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":16454,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[33],"tags":[],"class_list":["post-16478","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized-ro"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.0 (Yoast SEO v24.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>PIK3CA, POLE \u0219i MSI incluse \u00een ghidurile NCCN actualizate pentru a orienta terapia adjuvant\u0103 \u00een CCR \u00een stadiu incipient - Genekor<\/title>\n<meta name=\"description\" content=\"PIK3CA, POLE \u0219i MSI incluse \u00een Ghidurile NCCN 2025 pentru terapia adjuvant\u0103 \u00een cancerul de colon \u00een stadiu incipient | Com.pl.i.t DX Colon\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/genekor.com\/ro\/2025\/07\/15\/pik3ca-pole-msi-ghiduri-nccn-terapie-adjuvanta-cancer-colon-stadiu-incipient\/\" \/>\n<meta property=\"og:locale\" content=\"ro_RO\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"PIK3CA, POLE \u0219i MSI incluse \u00een ghidurile NCCN actualizate pentru a orienta terapia adjuvant\u0103 \u00een CCR \u00een stadiu incipient\" \/>\n<meta property=\"og:description\" content=\"PIK3CA, POLE \u0219i MSI incluse \u00een Ghidurile NCCN 2025 pentru terapia adjuvant\u0103 \u00een cancerul de colon \u00een stadiu incipient | Com.pl.i.t DX Colon\" \/>\n<meta property=\"og:url\" content=\"https:\/\/genekor.com\/ro\/2025\/07\/15\/pik3ca-pole-msi-ghiduri-nccn-terapie-adjuvanta-cancer-colon-stadiu-incipient\/\" \/>\n<meta property=\"og:site_name\" content=\"Genekor\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/genekorbiotechnology\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-07-15T13:30:18+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-07-16T06:35:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/genekor.com\/wp-content\/uploads\/2025\/07\/f1c8313f-2a68-371b-9b88-90d6e6e6f965.png\" \/>\n\t<meta property=\"og:image:width\" content=\"700\" \/>\n\t<meta property=\"og:image:height\" content=\"394\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Ioanna Potska\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Scris de\" \/>\n\t<meta name=\"twitter:data1\" content=\"Ioanna Potska\" \/>\n\t<meta name=\"twitter:label2\" content=\"Timp estimat pentru citire\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/genekor.com\/ro\/2025\/07\/15\/pik3ca-pole-msi-ghiduri-nccn-terapie-adjuvanta-cancer-colon-stadiu-incipient\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/genekor.com\/ro\/2025\/07\/15\/pik3ca-pole-msi-ghiduri-nccn-terapie-adjuvanta-cancer-colon-stadiu-incipient\/\"},\"author\":{\"name\":\"Ioanna Potska\",\"@id\":\"https:\/\/genekor.com\/ro\/#\/schema\/person\/d6c43cd4b4be66582d408967392cbcbd\"},\"headline\":\"PIK3CA, POLE \u0219i MSI incluse \u00een ghidurile NCCN actualizate pentru a orienta terapia adjuvant\u0103 \u00een CCR \u00een stadiu incipient\",\"datePublished\":\"2025-07-15T13:30:18+00:00\",\"dateModified\":\"2025-07-16T06:35:11+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/genekor.com\/ro\/2025\/07\/15\/pik3ca-pole-msi-ghiduri-nccn-terapie-adjuvanta-cancer-colon-stadiu-incipient\/\"},\"wordCount\":355,\"publisher\":{\"@id\":\"https:\/\/genekor.com\/ro\/#organization\"},\"image\":{\"@id\":\"https:\/\/genekor.com\/ro\/2025\/07\/15\/pik3ca-pole-msi-ghiduri-nccn-terapie-adjuvanta-cancer-colon-stadiu-incipient\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/genekor.com\/wp-content\/uploads\/2025\/07\/f1c8313f-2a68-371b-9b88-90d6e6e6f965.png\",\"articleSection\":[\"Uncategorized @ro\"],\"inLanguage\":\"ro-RO\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/genekor.com\/ro\/2025\/07\/15\/pik3ca-pole-msi-ghiduri-nccn-terapie-adjuvanta-cancer-colon-stadiu-incipient\/\",\"url\":\"https:\/\/genekor.com\/ro\/2025\/07\/15\/pik3ca-pole-msi-ghiduri-nccn-terapie-adjuvanta-cancer-colon-stadiu-incipient\/\",\"name\":\"PIK3CA, POLE \u0219i MSI incluse \u00een ghidurile NCCN actualizate pentru a orienta terapia adjuvant\u0103 \u00een CCR \u00een stadiu incipient - Genekor\",\"isPartOf\":{\"@id\":\"https:\/\/genekor.com\/ro\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/genekor.com\/ro\/2025\/07\/15\/pik3ca-pole-msi-ghiduri-nccn-terapie-adjuvanta-cancer-colon-stadiu-incipient\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/genekor.com\/ro\/2025\/07\/15\/pik3ca-pole-msi-ghiduri-nccn-terapie-adjuvanta-cancer-colon-stadiu-incipient\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/genekor.com\/wp-content\/uploads\/2025\/07\/f1c8313f-2a68-371b-9b88-90d6e6e6f965.png\",\"datePublished\":\"2025-07-15T13:30:18+00:00\",\"dateModified\":\"2025-07-16T06:35:11+00:00\",\"description\":\"PIK3CA, POLE \u0219i MSI incluse \u00een Ghidurile NCCN 2025 pentru terapia adjuvant\u0103 \u00een cancerul de colon \u00een stadiu incipient | Com.pl.i.t DX Colon\",\"breadcrumb\":{\"@id\":\"https:\/\/genekor.com\/ro\/2025\/07\/15\/pik3ca-pole-msi-ghiduri-nccn-terapie-adjuvanta-cancer-colon-stadiu-incipient\/#breadcrumb\"},\"inLanguage\":\"ro-RO\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/genekor.com\/ro\/2025\/07\/15\/pik3ca-pole-msi-ghiduri-nccn-terapie-adjuvanta-cancer-colon-stadiu-incipient\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ro-RO\",\"@id\":\"https:\/\/genekor.com\/ro\/2025\/07\/15\/pik3ca-pole-msi-ghiduri-nccn-terapie-adjuvanta-cancer-colon-stadiu-incipient\/#primaryimage\",\"url\":\"https:\/\/genekor.com\/wp-content\/uploads\/2025\/07\/f1c8313f-2a68-371b-9b88-90d6e6e6f965.png\",\"contentUrl\":\"https:\/\/genekor.com\/wp-content\/uploads\/2025\/07\/f1c8313f-2a68-371b-9b88-90d6e6e6f965.png\",\"width\":700,\"height\":394},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/genekor.com\/ro\/2025\/07\/15\/pik3ca-pole-msi-ghiduri-nccn-terapie-adjuvanta-cancer-colon-stadiu-incipient\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/genekor.com\/ro\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"PIK3CA, POLE \u0219i MSI incluse \u00een ghidurile NCCN actualizate pentru a orienta terapia adjuvant\u0103 \u00een CCR \u00een stadiu incipient\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/genekor.com\/ro\/#website\",\"url\":\"https:\/\/genekor.com\/ro\/\",\"name\":\"Genekor\",\"description\":\"Medicina personalizat\u0103\",\"publisher\":{\"@id\":\"https:\/\/genekor.com\/ro\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/genekor.com\/ro\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ro-RO\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/genekor.com\/ro\/#organization\",\"name\":\"Genekor\",\"url\":\"https:\/\/genekor.com\/ro\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ro-RO\",\"@id\":\"https:\/\/genekor.com\/ro\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/genekor.com\/wp-content\/uploads\/2021\/09\/logo-black.svg\",\"contentUrl\":\"https:\/\/genekor.com\/wp-content\/uploads\/2021\/09\/logo-black.svg\",\"width\":1,\"height\":1,\"caption\":\"Genekor\"},\"image\":{\"@id\":\"https:\/\/genekor.com\/ro\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/genekorbiotechnology\/\",\"https:\/\/gr.linkedin.com\/company\/genekor-sa\",\"https:\/\/www.youtube.com\/channel\/UCKC7sMFecVBY-OZAlRBHNzA\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/genekor.com\/ro\/#\/schema\/person\/d6c43cd4b4be66582d408967392cbcbd\",\"name\":\"Ioanna Potska\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ro-RO\",\"@id\":\"https:\/\/genekor.com\/ro\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/ef44ac80c13d1335f0ea78257146bbf1?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/ef44ac80c13d1335f0ea78257146bbf1?s=96&d=mm&r=g\",\"caption\":\"Ioanna Potska\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"PIK3CA, POLE \u0219i MSI incluse \u00een ghidurile NCCN actualizate pentru a orienta terapia adjuvant\u0103 \u00een CCR \u00een stadiu incipient - Genekor","description":"PIK3CA, POLE \u0219i MSI incluse \u00een Ghidurile NCCN 2025 pentru terapia adjuvant\u0103 \u00een cancerul de colon \u00een stadiu incipient | Com.pl.i.t DX Colon","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/genekor.com\/ro\/2025\/07\/15\/pik3ca-pole-msi-ghiduri-nccn-terapie-adjuvanta-cancer-colon-stadiu-incipient\/","og_locale":"ro_RO","og_type":"article","og_title":"PIK3CA, POLE \u0219i MSI incluse \u00een ghidurile NCCN actualizate pentru a orienta terapia adjuvant\u0103 \u00een CCR \u00een stadiu incipient","og_description":"PIK3CA, POLE \u0219i MSI incluse \u00een Ghidurile NCCN 2025 pentru terapia adjuvant\u0103 \u00een cancerul de colon \u00een stadiu incipient | Com.pl.i.t DX Colon","og_url":"https:\/\/genekor.com\/ro\/2025\/07\/15\/pik3ca-pole-msi-ghiduri-nccn-terapie-adjuvanta-cancer-colon-stadiu-incipient\/","og_site_name":"Genekor","article_publisher":"https:\/\/www.facebook.com\/genekorbiotechnology\/","article_published_time":"2025-07-15T13:30:18+00:00","article_modified_time":"2025-07-16T06:35:11+00:00","og_image":[{"width":700,"height":394,"url":"https:\/\/genekor.com\/wp-content\/uploads\/2025\/07\/f1c8313f-2a68-371b-9b88-90d6e6e6f965.png","type":"image\/png"}],"author":"Ioanna Potska","twitter_card":"summary_large_image","twitter_misc":{"Scris de":"Ioanna Potska","Timp estimat pentru citire":"2 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/genekor.com\/ro\/2025\/07\/15\/pik3ca-pole-msi-ghiduri-nccn-terapie-adjuvanta-cancer-colon-stadiu-incipient\/#article","isPartOf":{"@id":"https:\/\/genekor.com\/ro\/2025\/07\/15\/pik3ca-pole-msi-ghiduri-nccn-terapie-adjuvanta-cancer-colon-stadiu-incipient\/"},"author":{"name":"Ioanna Potska","@id":"https:\/\/genekor.com\/ro\/#\/schema\/person\/d6c43cd4b4be66582d408967392cbcbd"},"headline":"PIK3CA, POLE \u0219i MSI incluse \u00een ghidurile NCCN actualizate pentru a orienta terapia adjuvant\u0103 \u00een CCR \u00een stadiu incipient","datePublished":"2025-07-15T13:30:18+00:00","dateModified":"2025-07-16T06:35:11+00:00","mainEntityOfPage":{"@id":"https:\/\/genekor.com\/ro\/2025\/07\/15\/pik3ca-pole-msi-ghiduri-nccn-terapie-adjuvanta-cancer-colon-stadiu-incipient\/"},"wordCount":355,"publisher":{"@id":"https:\/\/genekor.com\/ro\/#organization"},"image":{"@id":"https:\/\/genekor.com\/ro\/2025\/07\/15\/pik3ca-pole-msi-ghiduri-nccn-terapie-adjuvanta-cancer-colon-stadiu-incipient\/#primaryimage"},"thumbnailUrl":"https:\/\/genekor.com\/wp-content\/uploads\/2025\/07\/f1c8313f-2a68-371b-9b88-90d6e6e6f965.png","articleSection":["Uncategorized @ro"],"inLanguage":"ro-RO"},{"@type":"WebPage","@id":"https:\/\/genekor.com\/ro\/2025\/07\/15\/pik3ca-pole-msi-ghiduri-nccn-terapie-adjuvanta-cancer-colon-stadiu-incipient\/","url":"https:\/\/genekor.com\/ro\/2025\/07\/15\/pik3ca-pole-msi-ghiduri-nccn-terapie-adjuvanta-cancer-colon-stadiu-incipient\/","name":"PIK3CA, POLE \u0219i MSI incluse \u00een ghidurile NCCN actualizate pentru a orienta terapia adjuvant\u0103 \u00een CCR \u00een stadiu incipient - Genekor","isPartOf":{"@id":"https:\/\/genekor.com\/ro\/#website"},"primaryImageOfPage":{"@id":"https:\/\/genekor.com\/ro\/2025\/07\/15\/pik3ca-pole-msi-ghiduri-nccn-terapie-adjuvanta-cancer-colon-stadiu-incipient\/#primaryimage"},"image":{"@id":"https:\/\/genekor.com\/ro\/2025\/07\/15\/pik3ca-pole-msi-ghiduri-nccn-terapie-adjuvanta-cancer-colon-stadiu-incipient\/#primaryimage"},"thumbnailUrl":"https:\/\/genekor.com\/wp-content\/uploads\/2025\/07\/f1c8313f-2a68-371b-9b88-90d6e6e6f965.png","datePublished":"2025-07-15T13:30:18+00:00","dateModified":"2025-07-16T06:35:11+00:00","description":"PIK3CA, POLE \u0219i MSI incluse \u00een Ghidurile NCCN 2025 pentru terapia adjuvant\u0103 \u00een cancerul de colon \u00een stadiu incipient | Com.pl.i.t DX Colon","breadcrumb":{"@id":"https:\/\/genekor.com\/ro\/2025\/07\/15\/pik3ca-pole-msi-ghiduri-nccn-terapie-adjuvanta-cancer-colon-stadiu-incipient\/#breadcrumb"},"inLanguage":"ro-RO","potentialAction":[{"@type":"ReadAction","target":["https:\/\/genekor.com\/ro\/2025\/07\/15\/pik3ca-pole-msi-ghiduri-nccn-terapie-adjuvanta-cancer-colon-stadiu-incipient\/"]}]},{"@type":"ImageObject","inLanguage":"ro-RO","@id":"https:\/\/genekor.com\/ro\/2025\/07\/15\/pik3ca-pole-msi-ghiduri-nccn-terapie-adjuvanta-cancer-colon-stadiu-incipient\/#primaryimage","url":"https:\/\/genekor.com\/wp-content\/uploads\/2025\/07\/f1c8313f-2a68-371b-9b88-90d6e6e6f965.png","contentUrl":"https:\/\/genekor.com\/wp-content\/uploads\/2025\/07\/f1c8313f-2a68-371b-9b88-90d6e6e6f965.png","width":700,"height":394},{"@type":"BreadcrumbList","@id":"https:\/\/genekor.com\/ro\/2025\/07\/15\/pik3ca-pole-msi-ghiduri-nccn-terapie-adjuvanta-cancer-colon-stadiu-incipient\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/genekor.com\/ro\/"},{"@type":"ListItem","position":2,"name":"PIK3CA, POLE \u0219i MSI incluse \u00een ghidurile NCCN actualizate pentru a orienta terapia adjuvant\u0103 \u00een CCR \u00een stadiu incipient"}]},{"@type":"WebSite","@id":"https:\/\/genekor.com\/ro\/#website","url":"https:\/\/genekor.com\/ro\/","name":"Genekor","description":"Medicina personalizat\u0103","publisher":{"@id":"https:\/\/genekor.com\/ro\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/genekor.com\/ro\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ro-RO"},{"@type":"Organization","@id":"https:\/\/genekor.com\/ro\/#organization","name":"Genekor","url":"https:\/\/genekor.com\/ro\/","logo":{"@type":"ImageObject","inLanguage":"ro-RO","@id":"https:\/\/genekor.com\/ro\/#\/schema\/logo\/image\/","url":"https:\/\/genekor.com\/wp-content\/uploads\/2021\/09\/logo-black.svg","contentUrl":"https:\/\/genekor.com\/wp-content\/uploads\/2021\/09\/logo-black.svg","width":1,"height":1,"caption":"Genekor"},"image":{"@id":"https:\/\/genekor.com\/ro\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/genekorbiotechnology\/","https:\/\/gr.linkedin.com\/company\/genekor-sa","https:\/\/www.youtube.com\/channel\/UCKC7sMFecVBY-OZAlRBHNzA"]},{"@type":"Person","@id":"https:\/\/genekor.com\/ro\/#\/schema\/person\/d6c43cd4b4be66582d408967392cbcbd","name":"Ioanna Potska","image":{"@type":"ImageObject","inLanguage":"ro-RO","@id":"https:\/\/genekor.com\/ro\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/ef44ac80c13d1335f0ea78257146bbf1?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ef44ac80c13d1335f0ea78257146bbf1?s=96&d=mm&r=g","caption":"Ioanna Potska"}}]}},"_links":{"self":[{"href":"https:\/\/genekor.com\/ro\/wp-json\/wp\/v2\/posts\/16478","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/genekor.com\/ro\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/genekor.com\/ro\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/genekor.com\/ro\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/genekor.com\/ro\/wp-json\/wp\/v2\/comments?post=16478"}],"version-history":[{"count":1,"href":"https:\/\/genekor.com\/ro\/wp-json\/wp\/v2\/posts\/16478\/revisions"}],"predecessor-version":[{"id":16480,"href":"https:\/\/genekor.com\/ro\/wp-json\/wp\/v2\/posts\/16478\/revisions\/16480"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/genekor.com\/ro\/wp-json\/wp\/v2\/media\/16454"}],"wp:attachment":[{"href":"https:\/\/genekor.com\/ro\/wp-json\/wp\/v2\/media?parent=16478"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/genekor.com\/ro\/wp-json\/wp\/v2\/categories?post=16478"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/genekor.com\/ro\/wp-json\/wp\/v2\/tags?post=16478"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}